Atlas Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity

Clinical trial NCT07559136 · RECRUITING

Trial details

NCT number
NCT07559136
Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Overweight and Obesity
Start date
2026-06-12
Primary completion
2027-02-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.